CTN Membership

The CTN Steering Group and all working groups include experienced researchers, healthcare professionals and people affected by MS.

Please email research@mssociety.org.uk if you would like to find out more information about CTN membership, particularly if you are interested in joining any of the CTN working groups.

CTN Steering Group Membership

Chair: Professor Sue Pavitt, University of Leeds
Terms of reference

  • Roger Bastow, Research Network
  • Professor Siddharthan Chandran, University of Edinburgh
  • Dr Jeremy Chataway, National Hospital for Neurology and Neurosurgery, London
  • Emma Delgado, Research Network
  • Professor Gavin Giovannoni, Barts and The London School of Medicine and Dentistry
  • Dr Raj Kapoor, National Hospital for Neurology and Neurosurgery, London
  • Professor David Miller, Institute of Neurology, University College London
  • Professor Rona Moss-Morris, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
  • Professor John Saxton, Northumbria University
  • Professor Kenneth Smith, Institute of Neurology, University College London
  • Professor Peter Thomas, Bournemouth University

Which treatments are effective for fatigue in people with MS? - CTN working group

Chair: Dr Jeremy Chataway, National Hospital for Neurology and Neurosurgery, London
Terms of reference

  • Carole Bennett, Research Network
  • Professor Jeremy Hobart, Peninsula Schools of Medicine and Dentistry,Plymouth University
  • Susan Hourihan, University College London
  • Professor Tom Mercer, Queen Margaret University
  • Professor Rona Moss-Morris, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
  • Professor John Saxton, Northumbria University
  • Kay-Anne Sheen, Research Network
  • Dr Sarah Thomas, Bournemouth University
  • Professor Peter Thomas, Bournemouth University
  • Dr Richard Warner, Gloucestershire Hospitals NHS Foundation Trust

Does early treatment with aggressive disease modifying treatment improve the prognosis for people with MS? - CTN working group

Chair: Professor David Miller, Institute of Neurology, University College London
Terms of reference

  • Professor Alasdair Coles, University of Cambridge
  • Gwen Covey-Crump, Research Network
  • Dr Matthew Craner, University of Oxford
  • Emma Delgado, Research Network
  • Dr Nikos Evangelou, University of Nottingham
  • Professor Gavin Giovannoni, Barts and The London School of Medicine and Dentistry
  • Professor Jeremy Hobart, Peninsula Schools of Medicine and Dentistry, Plymouth University
  • Dr Ana Manzano, University of Leeds
  • Rod Middleton, UK MS Register, Swansea University
  • Dr Paolo Muraro, Imperial College London
  • Professor Sue Pavitt, University of Leeds
  • Dr Klaus Schmierer, Barts and The London School of Medicine and Dentistry, University of London
  • Professor Neil Scolding, University of Bristol
  • Professor Neil Robertson, University of Cardiff

Is Vitamin D supplementation an effective disease modifying treatment for MS? - CTN working group

Chair: Professor Siddharthan Chandran, University of Edinburgh
Terms of reference

  • Roger Bastow, Research Network
  • Marie Braisher, Institute of Neurology, University College London
  • Dr Jeremy Chataway, National Hospital for Neurology and Neurosurgery, London
  • Dr Ruth Dobson, Barts and The London School of Medicine and Dentistry
  • Professor Gavin Giovannoni, Barts and The London School of Medicine and Dentistry
  • Professor Anna Madill, University of Leeds
  • Cal McGlaughlin, Research Network
  • Rod Middleton, UK MS Register, Swansea University
  • Dr Jennifer Nicholas, London School of Hygiene and Tropical Medicine
  • Professor Sue Pavitt, University of Leeds
  • Dr Klaus Witte, University of Leeds
  • Dr Daniel Altmann, London School of Hygiene and Tropical Medicine

 

What's new?